Detailed Information on Publication Record
2019
Physiology-based toxicokinetic modelling in the frame of the European Human Biomonitoring Initiative
SARIGIANNIS, Dimosthenis A., Spyros KARAKITSIOS, Elena DOMINGUEZ ROMERO, Krystalia PAPADAKI, Celine BROCHOT et. al.Basic information
Original name
Physiology-based toxicokinetic modelling in the frame of the European Human Biomonitoring Initiative
Authors
SARIGIANNIS, Dimosthenis A. (300 Greece), Spyros KARAKITSIOS (300 Greece), Elena DOMINGUEZ ROMERO (724 Spain, belonging to the institution), Krystalia PAPADAKI (300 Greece), Celine BROCHOT (250 France), Vikas KUMAR (724 Spain), Marta SCHUMACHER (724 Spain), Moustapha SY (276 Germany), Hans MIELKE (276 Germany), Mathias GREINER (276 Germany), Marcel MENGELERS (528 Netherlands) and Martin SCHERINGER (756 Switzerland, guarantor, belonging to the institution)
Edition
Environmental Research, SAN DIEGO, ACADEMIC PRESS INC ELSEVIER SCIENCE, 2019, 0013-9351
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30304 Public and environmental health
Country of publisher
United States of America
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 5.715
RIV identification code
RIV/00216224:14310/19:00110376
Organization unit
Faculty of Science
UT WoS
000468377500023
Keywords in English
PBTK modelling; Internal dose; Human biomonitoring; HBM4EU
Tags
Tags
International impact, Reviewed
Změněno: 24/3/2020 09:59, Mgr. Marie Šípková, DiS.
Abstract
V originále
Given the opportunities provided by internal dosimetry modelling in the interpretation of human biomonitoring (HBM) data, the assessment of the links between exposure to chemicals and observed HBM data can be effectively supported by PBTK modelling. This paper gives a comprehensive review of available human PBTK models for compounds selected as a priority by the European Human Biomonitoring Initiative (HBM4EU). We highlight their advantages and deficiencies and suggest steps for advanced internal dose modelling. The review of the available PBTK models highlighted the conceptual differences between older models compared to the ones developed recently, reflecting commensurate differences in research questions. Due to the lack of coordinated strategies for deriving useful biomonitoring data for toxicokinetic properties, significant problems in model parameterisation still remain; these are further increased by the lack of human toxicokinetic data due to ethics issues. Finally, questions arise as well as to the extent they are really representative of interindividual variability. QSARs for toxicokinetic properties is a complementary approach for PBTK model parameterisation, especially for data poor chemicals. This approach could be expanded to model chemico-biological interactions such as intestinal absorption and renal clearance; this could serve the development of more complex generic PBTK models that could be applied to newly derived chemicals. Another gap identified is the framework for mixture interaction terms among compounds that could eventually interact in metabolism. From the review it was concluded that efforts should be shifted toward the development of generic multi-compartmental and multi-route models, supported by targeted biomonitoring coupled with parameterisation by both QSAR approach and experimental (in-vivo and in-vitro) data for newly developed and data poor compounds.
Links
733032, interní kód MU |
|